Basics Neumora Therapeutics, Inc. IPO Date: September 15, 2023 Sector: Healthcare Industry: Biotech Market Cap: $355.17M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.71% Avg Daily Range (30 D): $0.09 | 3.64% Avg Daily Range (90 D): $0.08 | 3.84% Institutional Daily Volume Avg Daily Volume: .97M Avg Daily Volume (30 D): 1.07M Avg Daily Volume (90 D): 1.12M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 148 Avg Trade Size (Sh.) (90 D): 185 Institutional Trades Total Inst.Trades: 293 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $3.05M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $5.12M Avg Closing Trade (90 D): $5.12M Avg Closing Volume: 292.74K     News Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries Oct 1, 2025 @ 11:00 AM Neumora Therapeutics to Host Virtual R&D Day on Oc... Source: Helen Rubinstein Jul 23, 2025 @ 11:00 AM Neumora Therapeutics to Report Second Quarter 2025... Source: Helen Rubinstein Jul 9, 2025 @ 11:00 AM Neumora Therapeutics Announces Initiation of Phase... Source: Nick Brandon, Ph.D. May 28, 2025 @ 1:45 AM Kuehn Law Encourages Investors of Grocery Outlet H... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.35 $-.33 Diluted EPS $-.35 $-.33 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -56.76M $ -52.73M Operating Income / Loss $ $ -57.7M $ -54.04M Cost of Revenue $ $ $ Net Cash Flow $ $ 4.55M $ -18.84M PE Ratio